Naringin alleviates pneumonia caused by Klebsiella pneumoniae infection by suppressing NLRP3 inflammasome

文献类型： 外文期刊

第一作者： Jing, Xiao-Han

作者： Jing, Xiao-Han;Zhao, Guan-Yu;Wang, Gui-Bo;Huang, Qi-Lin;Zou, Wen-Shu;Huang, Li-Na;Li, Wei;Qiu, Zheng-Ying;Xin, Rui-Hua;Jing, Xiao-Han;Wang, Gui-Bo;Huang, Qi-Lin;Zou, Wen-Shu;Qiu, Zheng-Ying;Xin, Rui-Hua;Jing, Xiao-Han;Wang, Gui-Bo;Huang, Qi-Lin;Zou, Wen-Shu;Qiu, Zheng-Ying;Xin, Rui-Hua;Zhao, Guan-Yu;Huang, Li-Na;Li, Wei

作者机构：

关键词： Klebsiella pneumoniae; NLRP3 inflammasome; Naringin; Anti-inflammatory mechanism; Protein assembly

期刊名称：BIOMEDICINE & PHARMACOTHERAPY （ 影响因子：7.5； 五年影响因子：6.8 ）

ISSN： 0753-3322

年卷期： 2024 年 170 卷

页码：

收录情况： SCI

摘要： Klebsiella pneumoniae (Kpn) is an important pathogen of hospital-acquired pneumonia, which can lead to sepsis and death in severe cases. In this study, we simulated pneumonia induced by Kpn infection in mice to investigate the therapeutic effect of naringin (NAR) on bacterial-induced lung inflammation. Mice infected with Kpn exhibited increases in white blood cells (WBC) and neutrophils in the peripheral blood and pathological severe injury of the lungs. This injury was manifested by increased expression of the inflammatory cytokines interleukin (IL)- 18, IL-1 beta, tumor necrosis factor-alpha (TNF-alpha) and IL-6, and elevated the expression of NLRP3 protein. NAR treatment could decrease the protein expression of NLRP3, alleviate lung inflammation, and reduce lung injury in mice caused by Kpn. Meanwhile, molecular docking results suggest NAR could bind to NLRP3 and Surface Plasmon Resonance (SPR) analyses also confirm this result. In vitro trials, we found that pretreated with NAR not only inhibited nuclear translocation of nuclear factor (NF)-kappa B protein P65 but also attenuated the protein interaction of NLRP3, caspase-1 and ASC and inhibited the assembly of NLRP3 inflammasome in mice AMs. Additionally, NAR could reduce intracellular potassium (K+) efflux, inhibiting NLRP3 inflammasome activation. These results indicated that NAR could protect against Kpn-induced pneumonia by inhibiting the overactivation of the NLRP3 inflammasome signaling pathway. The results of this study confirm the efficacy of NAR in treating bacterial pneumonia, refine the mechanism of action of NAR, and provide a theoretical basis for the research and development of NAR as an anti-inflammatory adjuvant.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序